AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.

about

The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).

P2860

Q38729695-FE7CCE38-407C-40F0-87DF-9351BD6E4E8E

P2860

AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.

Item

http://www.wikidata.org/entity/Q38925954

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

AUY922 effectively targets aga ...... nuclear factor-κB activation.

@en

type

Item

label

AUY922 effectively targets aga ...... nuclear factor-κB activation.

@en

prefLabel

AUY922 effectively targets aga ...... nuclear factor-κB activation.

@en

P1476

AUY922 effectively targets aga ...... nuclear factor-κB activation.

@en

P2093

Hui-Jen Tsai

http://www.w3.org/2001/XMLSchema#string

Hui-You Lin

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Chang

http://www.w3.org/2001/XMLSchema#string

Kung-Chao Chang

http://www.w3.org/2001/XMLSchema#string

Li-Tzong Chen

http://www.w3.org/2001/XMLSchema#string

Neng-Yao Shih

http://www.w3.org/2001/XMLSchema#string

Sheng-Fung Lin

http://www.w3.org/2001/XMLSchema#string

Tsai-Yun Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

P304

2674-2682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2014.995647

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ann-Lii Cheng

Sung-Hsin Kuo

P577

2014-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270001952

http://www.w3.org/2001/XMLSchema#string

P698

25535814

http://www.w3.org/2001/XMLSchema#string

AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.

about

P2860

P2860

AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698